ACCESS Newswire

General Atomics

Share
Second RAF Protector Now Operating in Waddington

With Two Protector RPAs in the UK, GA-ASI Has Delivered a Total of 10 Protectors to RAF; First Four Cadres of RAF Aircrew Complete Training at FTTC

SAN DIEGO, CA / ACCESSWIRE / July 22, 2024 / The United Kingdom's Royal Air Force (RAF) now has two Protector RG Mk1 Remotely Piloted Aircraft (RPA) operating at RAF Waddington. The second Protector has started its ground trial at RAF Station Waddington with first flight expected in August. Protector is based on the MQ-9B SkyGuardian® RPA developed by General Atomics Aeronautical Systems, Inc. (GA-ASI), and is specially configured for the RAF. The RAF has taken delivery of 10 of their total order of 16 Protectors from GA-ASI, with eight aircraft currently undergoing RAF crew training, test, and evaluation in the United States.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.

"We're thrilled to see a second Protector operating at Waddington," said Chris Dusseault, GA-ASI's vice president of MQ-9B in Europe. "The Royal Air Force is a great partner for GA-ASI, and we look forward to additional MQ-9B aircraft operating in the U.K. and more broadly across Europe."

Simon Holford, Uncrewed Air Systems Delivery Team Leader at Defence Equipment & Support, said: "Seeing delivery and assembly of the second Protector aircraft in the UK is yet another measure of the significant progress on this project and testament to the hard work of everyone involved. Together with the three aircraft we have already taken delivery of in the U.S. (which remain in the U.S. for use in trials and/or training), we have now taken delivery of five of the 16 aircraft we have ordered."

Officer Commanding 31 Sqn, Wing Commander Maccoll, said, "I'm delighted to see another RAF Protector assembled at RAF Waddington, thanks to the hard work of our Programme team, Defence partners, contractors, and the skill of 31 Squadron personnel. This summer, Protector will undertake further test and evaluation and we expect more aircraft arrivals before the end of the year. "

In another program milestone, the first of four cadres of RAF aircrew completed training on April 29, 2024, at GA-ASI's Flight Test and Training Center (FTTC) in Grand Forks, North Dakota. The GA-ASI training involved RAF Operational Conversion Units (OCUs), which are comprised of eight crews, including pilots, sensor operators (SOs), and mission intelligence coordinators (MICs) from 31, 54, or 56 Squadrons.

The scope of the training is focused on foundational skills required to operate the Protector air vehicle and its equipment, including the Multi-Spectral Targeting System (MTS), Synthetic Aperture Radar (SAR), Mission Intelligence Station (MIS), and System for Tasking and Real-Time Exploitation (STARE). Training involves building solid foundations for both normal and emergency operations in Intelligence, Surveillance, and Reconnaissance (ISR) systems, instrument flying, and Automatic Takeoff and Landing Capability (ATLC).

With the completion of the Protector Technicians course at GA-ASI facilities in Southern California on May 16, 2024, Number 31 Squadron now has another 21 qualified maintainers. As part of their training course, the RAF maintainers were able to directly support the training flights for their aircrew counterparts who were completing the live flying element of their Operational Conversion course from North Dakota.

MQ-9B is GA-ASI's next-generation RPA System (RPAS), delivering exceptionally long endurance and range, with auto takeoff and landing under SATCOM-only control, and will be able to operate in unsegregated airspace using the GA-ASI-developed Detect and Avoid system. In addition to the RAF, contracts have been signed with Belgium, Canada, Taiwan and the U.S. Air Force in support of the Special Operations Command. The Japan Coast Guard is currently operating the MQ-9B for maritime operations, which the Japan Maritime Self-Defense Force (JMSDF) also selected for its Medium-Altitude, Long-Endurance (MALE) Remotely Piloted Aircraft System Trial Operation Project. MQ-9B has additionally supported various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, and Group Sail.

About GA-ASI

General Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable RPA systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent situational awareness. The company also produces a variety of sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas.

For more information, visit www.ga-asi.com.

Avenger, Lynx, Predator, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.

# # #

Contact Information

GA-ASI Media Relations
asi-mediarelations@ga-asi.com

SOURCE: General Atomics Aeronautical Systems, Inc.

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release

MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye

IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release

Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres

General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release

DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye